Relay Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 0.226 million compared to USD 0.419 million a year ago. Net loss was USD 94.24 million compared to USD 62.05 million a year ago.

Basic loss per share from continuing operations was USD 0.78 compared to USD 0.57 a year ago.